Andrew M Wardley (Andrew Wardley)

Scopus Author ID ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Topics

Early Breast Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

NPJ breast cancer

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Nicholas C Turner, A Douglas Laird, Melinda L Telli, Hope S Rugo, Audrey Mailliez, Johannes Ettl, Eva-Maria Grischke, Lida A Mina, Judith Balmaña, Peter Andreas Fasching, Sara Alsterlind Hurvitz, Julia F Hopkins, Lee A Albacker, Jijumon Chelliserry, Ying Chen, Umberto Conte, Andrew M Wardley, Mark E Robson
Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO study. NPJ breast cancer 9 (1) (2023)
Maria Coakley, Guillermo Villacampa, Prithika Sritharan, Claire Swift, Kathryn Dunne, Lucy Suzanne Kilburn, Katie Goddard, Christodoulos Pipinikas, Patricia Rojas, Warren Emmett, Peter S Hall, Catherine Harper-Wynne, Tamas Hickish, Iain R J Macpherson, Alicia F C Okines, Andrew M Wardley, Duncan A Wheatley, Simon H Waters, Carlo Palmieri, Matthew C Winter, Rosalind J Cutts, Isaac Garcia-Murillas, Judith M Bliss, Nicholas C Turner
Comparison of circulating tumor DNA assays for Molecular Residual Disease detection in early-stage triple negative breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Alistair Ring, Lucy Suzanne Kilburn, Alex Pearson, Laura Moretti, Angelica Afshari-Mehr, Andrew M Wardley, Bora Gurel, Iain R J Macpherson, Ruth Riisnaes, Richard D Baird, Sue Martin, Rebecca Roylance, Hannah Johnson, Ana Ferreira, Matthew C Winter, Kathryn Dunne, Ellen R Copson, Tamas Hickish, Russell Burcombe, Kat Randle, Violeta Serra, Alba Llop-Guevara, Judith M Bliss, Nicholas C Turner
Olaparib and celarasertib (AZD6738) in patients with triple negative advanced breast cancer: results from Cohort E of the plasmaMATCH trial (CRUK/15/010). Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Helena Earl, Louise Hiller, Anne-Laure Vallier, Shrushma Loi, Karen McAdam, Luke Hughes-Davies, Daniel W Rea, Donna Howe, Kerry Raynes, Helen B Higgins, Maggie Wilcox, Chris Plummer, Betania Mahler-Araujo, Elena Provenzano, Anita Chhabra, Sophie Gasson, Claire Balmer, Jean E Abraham, Carlos Caldas, Peter S Hall, Bethany Shinkins, Christopher McCabe, Claire T Hulme, David Miles, Andrew M Wardley, David A Cameron, Janet A Dunn
Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT. Health technology assessment (Winchester, England) 24 (40) (2021)
Eirini Thanopoulou, Leila Khader, Morena Caira, Andrew M Wardley, Johannes Ettl, Federica Miglietta, Patrick Neven, Valentina Guarneri
Therapeutic Strategies for the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Positive (HR+/HER2+) Breast Cancer: A Review of the Current Literature. Cancers 12 (11) (2020)
Nicholas C Turner, Melinda L Telli, Hope S Rugo, Audrey Mailliez, Johannes Ettl, Eva-Maria Grischke, Lida A Mina, Judith Balmaña, Peter Andreas Fasching, Sara A Hurvitz, Andrew M Wardley, Colombe Chappey, Alison L Hannah, Mark E Robson, null null
A Phase II Study of Talazoparib after Platinum or Cytotoxic Nonplatinum Regimens in Patients with Advanced Breast Cancer and Germline BRCA1/2 Mutations (ABRAZO). Clinical cancer research : an official journal of the American Association for Cancer Research 25 (9) (2018)
Andrew N J Tutt, Holly Tovey, Maggie Chon U Cheang, Sarah Kernaghan, Lucy Kilburn, Patrycja Gazinska, Julie Owen, Jacinta Abraham, Sophie Barrett, Peter Barrett-Lee, Robert Brown, Stephen Chan, Mitchell Dowsett, James M Flanagan, Lisa Fox, Anita Grigoriadis, Alexander Gutin, Catherine Harper-Wynne, Matthew Q Hatton, Katherine A Hoadley, Jyoti Parikh, Peter Parker, Charles M Perou, Rebecca Roylance, Vandna Shah, Adam Shaw, Ian E Smith, Kirsten M Timms, Andrew M Wardley, Gregory Wilson, Cheryl Gillett, Jerry S Lanchbury, Alan Ashworth, Nazneen Rahman, Mark Harries, Paul Ellis, Sarah E Pinder, Judith M Bliss
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial. Nature medicine 24 (5) (2018)